Antihyperlipidemic Drugs Market Report 2023-2028: Size, Share, Trends, Analysis & Research
The global antihyperlipidemic drugs market size reached US$ 12.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028.
The global antihyperlipidemic drugs market size reached US$ 12.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Report Description Report Description and Highlights
Competitive Landscape:
• Amgen Inc
• AstraZeneca plc
• Daiichi Sankyo Company Limited
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc
• Sanofi S.A.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/antihyperlipidemic-drugsmarket
Change language